Cargando…

The sodium–glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes

Sodium–glucose cotransporter 2 inhibitor (SGLT2i) treatment is a therapeutic approach for type 2 diabetes mellitus (T2DM). Some reports have shown that SGLT2i treatment improves insulin resistance; however, few studies have evaluated insulin resistance by the glucose clamp method. Hepatic insulin cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Kitao, Sonoko, Ito, Yuichi, Anno, Mari, Matsumoto, Kazuhisa, Shoji, Kyoko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Okura, Hiroko, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814145/ https://www.ncbi.nlm.nih.gov/pubmed/35115614 http://dx.doi.org/10.1038/s41598-022-05704-y

Ejemplares similares

Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report
por: Okura, Tsuyoshi, et al.
Publicado: (2022)

Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
por: Okura, Tsuyoshi, et al.
Publicado: (2020)

Significance of pancreatic duodenal homeobox-1 (PDX-1) genetic polymorphism in insulin secretion in Japanese patients with type 2 diabetes
por: Okura, Tsuyoshi, et al.
Publicado: (2022)

Aldehyde dehydrogenase 2 polymorphism is an important gene for insulin resistance in Japanese patients with type 2 diabetes
por: Okura, Tsuyoshi, et al.
Publicado: (2023)

Body mass index ≥23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report
por: Okura, Tsuyoshi, et al.
Publicado: (2018)

CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance—A preliminary research
por: Okura, Tsuyoshi, et al.
Publicado: (2018)

Correction: Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study
por: Nakamura, Risa, et al.
Publicado: (2019)

Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study
por: Nakamura, Risa, et al.
Publicado: (2017)

High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report
por: Okura, Tsuyoshi, et al.
Publicado: (2017)

Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C‐peptide immunoreactivity
por: Fujioka, Youhei, et al.
Publicado: (2017)

Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus
por: Ohkura, Tsuyoshi, et al.
Publicado: (2014)

Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study
por: Shiochi, Hideki, et al.
Publicado: (2014)

Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
por: Ohkura, Tsuyoshi, et al.
Publicado: (2014)

The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study
por: Ohkura, Tsuyoshi, et al.
Publicado: (2013)

Coenzyme Q10 suppresses apoptosis of mouse pancreatic β-cell line MIN6
por: Sumi, Keisuke, et al.
Publicado: (2018)

20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
por: Ohkura, Tsuyoshi, et al.
Publicado: (2013)

MON-595 Clinical Characteristics of Obstructive Sleep Apnea in Grave's Disease with Normal Thyroid Function
por: Matsumoto, Kazuhisa, et al.
Publicado: (2019)

A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study
por: Okura, Tsuyoshi, et al.
Publicado: (2018)

Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up
por: Ikeda, Suguru, et al.
Publicado: (2021)

Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
por: Choi, Min-Koo, et al.
Publicado: (2020)

Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report
por: Okada, Shuichi, et al.
Publicado: (2014)

Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms
por: Matsuzawa, Kazuhiko, et al.
Publicado: (2014)

Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome
por: Nagashima, Shuichi, et al.
Publicado: (2020)

Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Lean Mass in Patients With or Without Metformin Therapy
por: Nagai, Yoshio, et al.
Publicado: (2019)

Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case study
por: Okada, Junichi, et al.
Publicado: (2020)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
por: Kawata, Takehiro, et al.
Publicado: (2017)

Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
por: Kamezaki, Michitsugu, et al.
Publicado: (2018)

Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules
por: Hosokawa, Kohshiro, et al.
Publicado: (2019)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

The Improvement of the Hepatic Histological Findings in a Patient with Non-alcoholic Steatohepatitis with Type 2 Diabetes after the Administration of the Sodium-glucose Cotransporter 2 Inhibitor Ipragliflozin
por: Takeda, Akihiko, et al.
Publicado: (2017)

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet
por: Takagi, Susumu, et al.
Publicado: (2018)

An educational intervention improved knowledge of dietary supplements in college students
por: Chiba, Tsuyoshi, et al.
Publicado: (2020)

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Ipragliflozin/tozinameran: Diabetic ketoacidosis: 2 case reports
Publicado: (2022)

Evaluation of beneficial effect of a dual-task exercise based on Japanese transitional games in older adults: a pilot study
por: Yoon, Jieun, et al.
Publicado: (2020)

Effect of Citrulline and Leucine Intake with Exercises on Body Composition, Physical Activity, and Amino Acid Concentration in Older Women: A Randomized Double-Blind Placebo-Controlled Study
por: Kim, Mijin, et al.
Publicado: (2021)

Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
por: Kashiwagi, Atsunori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1mevekj3og8nkqgrb2k2348vl8